Deferasirox is designated chemically as 43,5bis2hydroxyphenyl1 h 1,2,4triazol1ylbenzoic. Clarithromycin paediatric suspension msds msdsdigital. Variants manufacturers product codes finished goods code. Deferasirox is used to treat iron overload caused by blood transfusions in adults and children at least 2 years old. Usp reference standards are rigorously tested and evaluated by multiple independent commercial, regulatory, and academic laboratories to confirm accuracy and reproducibility. Consider repaglinide dose reduction and monitor blood glucose levels. Vinyltrichlorosilane safety data sheet 06162015 en english us sds id.
Degarelix targets and blocks gnrh receptors located on the. Exjade deferasirox is indicated for the treatment of chronic iron overload due to blood transfusions transfusional hemosiderosis in patients 2 years of age and older. Deferasirox also displays both neuroprotective and chemotherapeutic benefit as well. Deferasirox marketed as exjade, desirox, defrijet, desifer, rasiroxpine and jadenu is an oral iron chelator. Efficacy and safety of deferasirox in nontransfusion. Monitor plasma concentrations of busulfan when coadministered with deferasirox to allow. If symptoms of poisoning become evident, contact a poisons information centre, or call a doctor at once. Buy deferasiroxd4 cas 13425758, a labeled tridentate iron chelator, from santa cruz. Safety data sheet according to 29cfr19101200 and ghs rev. Becton, dickinson and company bd, franklin lakes, nj 07417 usa. Deferasirox is orally administered and has demonstrated a good side. Deferasirox is one such agent and the drug has shown significant antitumor effects in a number of in vitro and in vivo studies. This is a randomized, openlabel, multicenter, two arm, phase ii study to evaluate treatment compliance and change in serum ferritin of a deferasirox granule formulation and a. Degarelix acetate is the acetate form of a longacting, synthetic peptide with gonadotrophinreleasing hormone antagonistic properties.
Accidental release measures accidental release measures. Bioboosttm all natural foliar fertilizer product no. The potential of deferasirox as a novel therapeutic. Wo2009067557a1 deferasirox pharmaceutical compositions. Active pharmaceutical ingredients lists of our established and commercially available pharmaceuticals apis are available as a pdf download here. Deferasirox pharmaceutical compositions download pdf. Exjade deferasirox tablets for oral suspension 4, 5. Deferasirox impurity 1 tlc pharmaceutical standards. The world s hardest floors cali bamboo material safety data sheet 6.
Absorb with liquidbinding material sand, diatomite, acid. Add new user a password link will be sent to this users email address make admin view only add user. Material safety data sheet msds section 2 hazardous ingredientsidentity information section 3 physicalchemical characteristics section 4 fire and explosion hazard data section 5. As such, the information in it must not be altered, deleted or added to. Deferasirox loaded on fumed silica nanoparticles used in.
Your new online msds binder is a place for you to store the material safety data sheets you need to deploy. We offer publicly available, official documentary standards for pharmaceutical ingredients in the usp. M of deferasirox for 24 or 48 h, and proliferation is determined by an mtt assay2. The information provided in this safety data sheet is correct to the best of our knowledge, information and belief at the date of its publication. Jadenu deferasirox is an ironchelating agent provided as a tablet or granules for oral use. Since the ic 50 of deferasirox was the lowest below 10.
This safety data sheet is issued by the supplier in accordance with whs ghs guidelines. Safety data sheet created using sdsonline creation tool. This material safety data sheet complies with the requirements of regulation ec no. Sds are documents that provide critical information about hazardous chemicals. Deferasirox binds to iron and removes it from the blood stream. Its main use is to reduce chronic iron overload in patients who are receiving longterm blood. In deferasiroxtreated patients with ntdt syndromes, the most frequently occurring greater than 5% adverse reactions are diarrhea, rash and. Sds of deferasirox, safety data sheets, cas 201530418. Exjade increases the exposure of the cyp2c8 substrate repaglinide. Illustration showing the effect of various amounts of mannitol and sds on dissolution. Dailymed jadenu deferasirox tablet, film coated jadenu.
Accidental release measures contain spill and collect, as appropriate. Study to evaluate treatment compliance, efficacy and. Ez street asphalt safety data sheet according to the federal final rule of hazard communication revised on 2012 hazcom 2012 03232015 en english 26 firstaid measures after ingestion. Deferasirox side effects, dosage, interactions drugs. Deferasirox is an iron chelator commonly used to treat ironoverload disease. Safety data sheet according to federal register vol. Its main use is to reduce chronic iron overload in patients. Efficacy and safety of deferasirox in nontransfusion dependent thalassemia patients with iron overload and a one year openlabel extension study thalassa the safety and scientific. Deferasirox has a survival benefit for sio leukemia murine model in terms of iron chelation and antileukemic therapy3.
753 61 228 1010 1491 1297 707 542 936 1161 468 145 269 994 1427 1137 796 1116 391 1331 1250 96 441 1179 1397 1363 780 488 1046 355 1330 998 628